Nektar releases promising phase 2 results for NKTR-255 in lymphopenia
| IMANX Fund | USD 16.80 0.05 0.30% |
Slightly above 62% of Iman Fund's investor base is looking to short. The analysis of overall sentiment of trading Iman Fund Class mutual fund suggests that many investors are alarmed at this time. Iman Fund's investing sentiment can be driven by a variety of factors including economic data, Iman Fund's earnings reports, geopolitical events, and overall market trends.
Iman |
Nektar Therapeutics reports positive interim data on NKTR-255 in combination with Imfinzi for lung cancer patients, reversing radiation induced lymphopenia. Read more here.
Read at seekingalpha.com
 |
Iman Fund Fundamental Analysis
We analyze Iman Fund's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Iman Fund using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Iman Fund based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Three Year Return
Three Year Return Comparative Analysis
Iman Fund is currently under evaluation in three year return among similar funds. Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.
Iman Fund Class Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Iman Fund mutual fund to make a market-neutral strategy. Peer analysis of Iman Fund could also be used in its relative valuation, which is a method of valuing Iman Fund by comparing valuation metrics with similar companies.
Peers
Iman Fund Related Equities
| CGFFX | Growth Fund | 0.21 |
| ||
| CGFEX | Growth Fund | 0.21 |
| ||
| GFAFX | Growth Fund | 0.22 |
| ||
| RGAEX | Growth Fund | 0.22 |
| ||
| FFAFX | American Funds | 0.87 |
| ||
| GFACX | Growth Fund | 0.88 |
| ||
| CGFAX | Growth Fund | 0.88 |
| ||
| CGFCX | Growth Fund | 0.88 |
| ||
| FAFGX | American Funds | 0.88 |
|
Other Information on Investing in Iman Mutual Fund
Iman Fund financial ratios help investors to determine whether Iman Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Iman with respect to the benefits of owning Iman Fund security.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |